Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × ispinesib × Clear all

NCT00096499 2013-01-25

SB-715992 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Docetaxel or Paclitaxel

Phase 2 Completed

Prostatic Neoplasms